Antithrombotic therapy for patients with atrial fibrillation and stable coronary artery disease of 1-year and 3-year after percutaneous coronary intervention: a nationwide population-based study

被引：0
|
作者：
Lee, S. R. [1 ]
Jung, J. H. [2 ]
Choi, E. K. [1 ]
Lee, S. W. [2 ]
Kwon, S. [1 ]
Park, J. S. [1 ]
Han, K. D. [3 ]
Oh, S. [1 ]
Lip, G. Y. H. [4 ]
机构：
[1] Seoul Natl Univ Hosp, Dept Internal Med, Div Cardiol, Seoul, South Korea
[2] Catholic Univ Korea, Seoul, South Korea
[3] Soongsil Univ, Seoul, South Korea
[4] Univ Liverpool, Liverpool, Merseyside, England
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2930 / 2930
页数：1
相关论文
共 50 条
  • [1] Antithrombotic therapy in acute coronary syndrome and stable coronary artery disease patients with atrial fibrillation: a 3-year retrospective cohort study
    Wu, Jun
    Lin, Shenglan
    Men, Chen
    Wang, Xiangming
    Wang, Sen
    Hong, Jian
    Xu, Di
    Guo, Yan
    PERSONALIZED MEDICINE, 2019, 16 (05) : 399 - 407
  • [2] Antithrombotic Therapy in Patients With Atrial Fibrillation and Coronary Artery Disease Undergoing Percutaneous Coronary Intervention
    Mishra, Abhishek
    Singh, Maninder
    Acker, Warren W.
    Kamboj, Sukriti
    Sporn, Daniel
    Stapleton, Dwight
    Kaluski, Edo
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2019, 74 (02) : 82 - 90
  • [3] Antithrombotic treatment beyond 1 year after percutaneous coronary intervention in patients with atrial fibrillation
    Jensen, Thomas
    Thrane, Pernille G.
    Olesen, Kevin K. W.
    Wurtz, Morten
    Mortensen, Martin Bodtker
    Gyldenkerne, Christine
    Thim, Troels
    Norgaard, Bjarne Linde
    Jensen, Jesper Moller
    Kristensen, Steen Dalby
    Nielsen, Jens C.
    Eikelboom, John W.
    Maeng, Michael
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2023, 9 (03) : 208 - 219
  • [4] Optimal Antithrombotic Therapy Beyond 1-Year After Coronary Revascularization in Patients With Atrial Fibrillation
    Kim, Jihoon
    Kang, Danbee
    Kim, Hyunsoo
    Park, Hyejeong
    Park, Taek Kyu
    Lee, Joo Myung
    Yang, Jeong Hoon
    Song, Young Bin
    Choi, Jin-Ho
    Choi, Seung-Hyuk
    Gwon, Hyeon-Cheol
    Guallar, Eliseo
    Cho, Juhee
    Hahn, Joo-Yong
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2024, 39 (24) : e191
  • [5] Antithrombotic Therapy in Patients With Atrial Fibrillation After Percutaneous Coronary Intervention During 2-Year Follow-Up, from a Nationwide Population Study
    Park, Jiesuck
    Choi, Eue-Keun
    Han, Kyung-Do
    Choi, You-Jung
    Lee, So-Ryoung
    Cha, Myung-Jin
    Kang, Jeehoon
    Park, Kyung Woo
    Oh, Seil
    Lip, Gregory Y. H.
    AMERICAN JOURNAL OF CARDIOLOGY, 2019, 123 (12): : 1921 - 1926
  • [6] Antithrombotic therapy in patients with atrial fibrillation after percutaneous coronary intervention
    Sammut, Mark Anthony
    Storey, Robert F.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2024, 22 (09) : 471 - 482
  • [7] Antithrombotic Therapy After Percutaneous Coronary Intervention in Atrial Fibrillation
    Godino, Cosmo
    Pivato, Carlo Andrea
    Rubino, Claudia
    Russi, Anita
    Cera, Michela
    Margonato, Alberto
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 129 : 122 - 124
  • [8] Antithrombotic regimens in patients with atrial fibrillation and coronary artery disease after percutaneous coronary intervention: A focused review
    Chang, Kay-Won
    Arbit, Boris
    Hsu, Jonathan C.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 243 : 263 - 269
  • [9] Antithrombotic Therapy During and After Percutaneous Coronary Intervention in Patients With Atrial Fibrillation
    Verheugt, Freek W. A.
    CIRCULATION, 2013, 128 (18) : 2058 - 2061
  • [10] Clinical characteristics and one year outcomes in Chinese atrial fibrillation patients with stable coronary artery disease:a population-based study
    Ying BAI
    Jun ZHU
    Yan-Min YANG
    Yan LIANG
    Hui-Qiong TAN
    Juan WANG
    Bi HUANG
    Han ZHANG
    Xing-Hui SHAO
    Journal of Geriatric Cardiology, 2016, 13 (08) : 665 - 671
12345